Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AARD

Aardvark Therapeutics Inc

Feb 21 • 04:00PM ET

13.74

Dollar change -3.51
Percentage change -20.35	%

Healthcare • Biotechnology • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	55.99%	Shs Outstand	131.47M	Perf Week	-3.98%
Market Cap	1.81B	Forward P/E	-	EPS next Y	-	Insider Trans	2.03%	Shs Float	57.86M	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	0.75%	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-2.16	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	0.63	P/C	21.93	EPS next 5Y	-	ROE	-	52W Range	11.55 - 19.58	Perf YTD	-3.98%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-29.83%	Beta	-
Dividend TTM	-	Quick Ratio	31.65	Sales past 5Y	0.00%	Gross Margin	-	52W Low	18.96%	ATR (14)	3.12
Dividend Ex-Date	-	Current Ratio	31.65	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	20.73% -
Employees	-	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	-	Payout	-	Rel Volume	0.45	Prev Close	17.25
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	538.39K	Price	13.74
SMA20	-5.31%	SMA50	-5.31%	SMA200	-5.31%	Trades		Volume	241,427	Change	-20.35%

Feb-12-25 10:38PM

Aardvark Therapeutics Announces Pricing of Initial Public Offering

(GlobeNewswire)

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Decheng Capital Global Life Sc	10% Owner	Feb 14 '25	Buy	16.00	1,250,000	20,000,000	2,958,887	Feb 19 05:44 PM
Lee Tien-Li	Chief Executive Officer	Feb 14 '25	Buy	16.00	16,542	264,672	1,496,175	Feb 19 04:35 PM
Sun Nelson	Chief Financial Officer	Feb 14 '25	Buy	16.00	10,000	160,000	99,484	Feb 19 04:30 PM
Cormorant Asset Management, LP	Former 10% Owner	Feb 14 '25	Buy	16.00	187,500	3,000,000	987,689	Feb 19 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AARD

Aardvark Therapeutics Inc

Upgrade your FINVIZ experience